Drug Name |
Gentamicin
|
||
Synonyms |
Alcomicin; Apogen; Bristagen; Cidomycin; GENTAMYCIN; Garamycin; Garasol; Gentacidin; Gentacycol; Gentafair; Gentak; Gentamar; Gentamicina; Gentamicine; Gentamicins; Gentamicinum; Gentamycinum; Gentavet; Gentocin; Jenamicin; Refobacin; Uromycine; Garamycin Otic Solution; Genoptic Liquifilm; Gentamcin Sulfate; Gentamicin sulphate sterile; Refobacin TM; Gentamicin C1; G-Mycin; G-Myticin; Garamycin (TN); Gentamicin (BAN); Gentamicin (TN); Gentamicina [INN-Spanish]; Gentamicine [INN-French]; Gentamicinum [INN-Latin];Gentamycin-creme; Gentamycin-creme [German]; Ocu-Mycin; Spectro-Genta; U-Gencin; Genoptic S.O.P.; O-2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-alpha-D-ribo-heptopyranosyl-(1-4)-O-(3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl-(1-6))-2-deoxy-D-streptamine; (1R,2S,3S,4R,6S)-4,6-diamino-3-[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyloxy]-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-beta-L-lyxo-heptopyranoside; (1R,2S,3S,4R,6S)-4,6-diamino-3-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-2-hydroxycyclohexyl (6x)-2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-alpha-D-erythro-heptopyranoside; (2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol; 2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol; 4,6-diamino-3-{[3-deoxy-4-c-methyl-3-(methylamino)pentopyranosyl]oxy}-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)heptopyranoside
|
||
Drug Type |
Small molecular drug
|
||
Indications |
Bacterial infection [ICD-11: 1A00-1C4Z; ICD-10: A00-B99]
|
Approved
|
|
Company |
Sandoz
|
||
Summary |
Gentamicin is an aminoglycoside used to treat a wide variety of aerobic infections in the body.
|
||
Target |
Bacterial 30S ribosomal RNA (Bact 30S rRNA)
Mechanism of Action: Modulator
|
T62094 |
![]() |
Formula |
C21H43N5O7
|
Canonical SMILES |
CC(C1CCC(C(O1)OC2C(CC(C(C2O)OC3C(C(C(CO3)(C)O)NC)O)N)N)N)NC
|
|
InChI |
1S/C21H43N5O7/c1-9(25-3)13-6-5-10(22)19(31-13)32-16-11(23)7-12(24)17(14(16)27)33-20-15(28)18(26-4)21(2,29)8-30-20/h9-20,25-29H,5-8,22-24H2,1-4H3
|
|
InChIKey |
CEAZRRDELHUEMR-UHFFFAOYSA-N
|
|
CAS Number | CAS 1403-66-3 | |
TTD ID | D0L9UU | |
DrugBank ID | DB00798 | |
PubChem Compound ID | 3467 | |
PubChem Substance ID |
4652583
,
8152203
,
29222600
,
46506523
,
49972189
,
53787495
,
57321817
,
74460187
,
92712501
,
96024706
,
103135455
,
104303599
,
117535962
,
124766025
,
126407615
,
126625531
,
126661266
,
126691181
,
127340104
,
127340105
,
127340106
,
134337440
,
134980500
,
135650301
,
137239444
,
142147875
,
152100630
,
160964140
,
196105377
,
223658860
,
226847630
,
242084438
,
246167234
,
250134950
|
|
ChEBI ID | NA | |
ADReCS Drug ID | BADD_D01016 |
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship Classification | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ID | Name | Dose | Type | Drug Brand Name | Drug Dose | Drug Dosage Form | Experimental Species | Individuals Number | Test Sample | Ingredient | Effect | Relationship classification |